Weave to Present at Raymond James 47th Annual Institutional Investors Conference

Weave (NYSE: WEAV), a prominent provider of AI-driven patient engagement and payment solutions tailored for small and medium-sized healthcare practices, has announced its participation in the upcoming 47th Annual Raymond James Institutional Investors Conference. This influential event is set to take place on March 2, 2026, at the JW Marriott Grande Lakes in Orlando, Florida. Weave’s CEO, Brett White, and CFO, Jason Christiansen, will lead a fireside chat presentation at 4:35 pm ET, where they will share insights about the company’s innovative solutions and strategies. Additionally, they will engage in one-on-one meetings with investors.

The fireside chat will be broadcast live on the Weave Investor Relations website and will be available for on-demand viewing shortly after its conclusion, providing stakeholders and interested parties with accessible updates on the company’s developments.

Weave distinguishes itself as a leading AI-powered platform that enhances patient communications and engagement, specifically designed for small to mid-sized healthcare providers. By streamlining patient interactions through a blend of AI agents and staff communication—integrating both voice and text interactions—Weave enhances the overall patient experience. Its platform facilitates essential practice operations, such as appointment scheduling, insurance eligibility verification, and payment collection, making administrative tasks more efficient.

With nearly 40,000 customer locations served, Weave has received recognition as a 2026 Best Software Awards winner for healthcare software by G2, affirming its value in the industry. Investors and healthcare stakeholders are encouraged to learn more about Weave and its offerings by visiting their website.

Weave (NYSE: WEAV) is poised for a significant opportunity as it prepares to present at the upcoming Raymond James 47th Annual Institutional Investors Conference. With its innovative vertical SaaS solutions designed for small and medium-sized healthcare practices, Weave positions itself at a critical intersection of health tech and patient engagement, where demand is steadily increasing.

The company's AI-powered platform streamlines patient communications and elevates operational efficiency, addressing a critical need in the healthcare industry for enhanced patient interactions. Given that Weave services nearly 40,000 locations, there is a robust validation of its product-market fit which investors should note closely.

During the conference, CEO Brett White and CFO Jason Christiansen will host a fireside chat at 4:35 pm ET. This presents investors with an invaluable chance to gain insights directly from Weave's leadership regarding the company’s growth strategies and market positioning. The live webcast will also allow interested parties to engage interactively, offering an opportunity to delve deeper into Weave's operational methodologies and future roadmap.

Investors should consider the implications of Weave's growth trajectory in the context of the healthcare market's transformation. As practices increasingly adopt technology to manage patient relationships and operational efficiencies, Weave stands to benefit significantly. The recognition as a 2026 Best Software Awards winner by G2 further underscores its competitive edge and the potential for continued expansion.

In conclusion, Weave's upcoming presentation at Raymond James represents an essential moment for potential and current investors. It is advisable to monitor the outcomes and insights from the chat closely, as they may set the stage for Weave's prospective growth in a rapidly evolving healthcare environment.